In the BioHarmony Drug Report Database
Propulsid, Propulsid Quicksolv (cisapride) is a small molecule pharmaceutical. Cisapride was first approved as Propulsid on 1993-07-29. It is used to treat constipation, dyspepsia, gastroesophageal reflux, and gastroparesis in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 4. In addition, it is known to target 5-hydroxytryptamine receptor 7 and potassium voltage-gated channel subfamily H member 2.
Image (chem structure or protein)